Women with IGF-1 concentrations in the top 20% were shown to have a 1.24-fold increased chance of developing breast cancer compared to those in the bottom 20%, after adjustments for factors including age, body mass index and concentrations of other hormones and proteins in the blood. This evidence concerns the gene IGF1 and breast carcinoma.